Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Greenland Mines Ltd. Common Stock (NASDAQ:GRML) to a sell rating in a research note issued to investors on Saturday,Wall Street Zen reports.

Separately, Weiss Ratings raised Greenland Mines Ltd. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, August 25th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

Greenland Mines Ltd. Common Stock Stock Down 0.6%

Shares of NASDAQ:GRML opened at $4.85 on Friday. The stock has a market cap of $15.42 million, a PE ratio of -15.16 and a beta of 7.13. The company’s fifty day moving average is $10.06 and its 200 day moving average is $17.37. Greenland Mines Ltd. Common Stock has a 52 week low of $4.37 and a 52 week high of $36.99.

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) last posted its quarterly earnings results on Monday, August 17th. The company reported ($0.03) earnings per share (EPS) for the quarter.

Insider Transactions at Greenland Mines Ltd. Common Stock

In other news, Director Jason David Sawyer bought 4,800 shares of the firm’s stock in a transaction that occurred on Wednesday, July 22nd. The shares were bought at an average cost of $11.50 per share, with a total value of $55,200.00. Following the completion of the purchase, the director directly owned 4,800 shares in the company, valued at $55,200. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, CFO Jeff Leblanc purchased 14,000 shares of the stock in a transaction that occurred on Tuesday, August 25th. The shares were purchased at an average price of $9.72 per share, with a total value of $136,080.00. Following the completion of the acquisition, the chief financial officer directly owned 110,406 shares in the company, valued at $1,073,146.32. The trade was a 14.52% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Company insiders own 11.30% of the company’s stock.

Institutional Investors Weigh In On Greenland Mines Ltd. Common Stock

Large investors have recently added to or reduced their stakes in the company. Jane Street Group LLC purchased a new position in shares of Greenland Mines Ltd. Common Stock in the second quarter valued at about $26,000. XTX Topco Ltd boosted its holdings in shares of Greenland Mines Ltd. Common Stock by 101.2% during the fourth quarter. XTX Topco Ltd now owns 160,569 shares of the company’s stock worth $46,000 after purchasing an additional 80,768 shares during the period. Renaissance Technologies LLC purchased a new position in Greenland Mines Ltd. Common Stock during the 4th quarter valued at about $126,000. Geode Capital Management LLC increased its holdings in Greenland Mines Ltd. Common Stock by 51.8% during the 4th quarter. Geode Capital Management LLC now owns 491,832 shares of the company’s stock valued at $142,000 after purchasing an additional 167,905 shares during the period. Finally, Brummer Multi Strategy AB purchased a new position in Greenland Mines Ltd. Common Stock during the 4th quarter valued at about $175,000. Institutional investors own 20.07% of the company’s stock.

Greenland Mines Ltd. Common Stock Company Profile

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.